Identification of a FUS splicing mutation in a large family with amyotrophic lateral sclerosis

Véronique V. Belzil, Judith St-Onge, Hussein Daoud, Anne Desjarlais, Jean Pierre Bouchard, Nicolas Dupré, William Camu, Patrick A. Dion, Guy A. Rouleau

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease characterized by the degeneration of upper and lower motor neurons. Genetic studies have led, thus far, to the identification of 12 loci and 9 genes for familial ALS (FALS). Although the distribution and impact of superoxide dismutase 1 mutations has been extensively examined for over a decade, the recently identified FALS-associated FUS gene has been less studied. Therefore, we set out to screen our collection of FALS cases for FUS mutations. All 15 exons of FUS were amplified and sequenced in 154 unrelated FALS cases and 475 ethnically matched healthy individuals. One substitution located in the acceptor splice site of intron 14 was identified in all affected members of a large family, causing the skipping of the last 13 amino acids of the protein and the translation of 7 novel amino acids, resulting from the new translation of a part of the 3′ untranslated region. Our study identified a new splicing mutation in the highly conserved C-terminal of the FUS protein. Thus far most FUS mutations are missenses, and our findings, combined with those of others, confirm the importance of the C-terminal portion of the protein, adding additional support for FUS mutations having a critical role in ALS.

Original languageEnglish (US)
Pages (from-to)247-249
Number of pages3
JournalJournal of Human Genetics
Issue number3
StatePublished - Mar 2011


  • FUS/motor neuron disease
  • RNA-binding protein
  • amyotrophic lateral sclerosis
  • neurodegeneration
  • splicing mutation

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)


Dive into the research topics of 'Identification of a FUS splicing mutation in a large family with amyotrophic lateral sclerosis'. Together they form a unique fingerprint.

Cite this